Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion type Assertion NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_head.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion description "[Rarity of second-hit inactivation of the involved gene in CHEK2-, NBN/NBS1- and BLM-associated BC demonstrates their substantial biological difference from BRCA1/2-driven cancers and makes them poorly suitable for the clinical trials with cisplatin and PARP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_provenance.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion evidence source_evidence_literature NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_provenance.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion SIO_000772 24415413 NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_provenance.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion wasDerivedFrom befree-2016 NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_provenance.
- NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_assertion wasGeneratedBy ECO_0000203 NP1144260.RAMadERLPVQ6WqracjFOFQDLw4qKAjjZfxx3xRKfn_jPc130_provenance.